Top Stories
Top Stories
Wires

ASTELLAS PHARMA, SEATTLE GENETICS DRUG SHRINKS TUMORS IN 44% OF ADVANCED BLADDER CANCER PATIENTS, INCLUDING 12% COMPLETE RESPONSES - STUDY